MyFinsight
Home
Blog
About
Cash
$7,694K
(183.81%↑ Y/Y)
Prepaid expenses
$532K
(19.02%↑ Y/Y)
Restricted cash
$60K
(0.00%↑ Y/Y)
Other current assets
$38K
(-54.22%↓ Y/Y)
Other intangible
assets
$30,300K
(-22.66%↓ Y/Y)
Total current assets
$8,324K
(152.17%↑ Y/Y)
Total assets
$38,624K
(-24.13%↓ Y/Y)
Total liabilities and
shareholders equity
$38,624K
(-24.13%↓ Y/Y)
Total liabilities
$20,029K
(-20.85%↓ Y/Y)
Total shareholders
equity
$18,595K
(-27.38%↓ Y/Y)
Accumulated deficit
-$283,812K
(-12.24%↓ Y/Y)
Accumulated other
comprehensive loss
-$695K
(37.16%↑ Y/Y)
Total current
liabilities
$13,935K
(-18.69%↓ Y/Y)
Deferred tax liability
$6,094K
(-24.20%↓ Y/Y)
Additional paid-in capital
$243,759K
(10.38%↑ Y/Y)
Capital redemption
reserve
$59,342K
(13.70%↑ Y/Y)
Authorized
4,365,687,180,943 and...
$1K
(-99.98%↓ Y/Y)
Accounts payable
$9,401K
(-19.01%↓ Y/Y)
Accrued expenses
$3,513K
(42.34%↑ Y/Y)
Convertible notes, net
$693K
(-1.00%↓ Y/Y)
Other current
liabilities
$212K
(-67.38%↓ Y/Y)
Warrant liabilities
$116K
(-86.61%↓ Y/Y)
Back
Back
Balance Sheet
Akari Therapeutics Plc (AKTX)
Akari Therapeutics Plc (AKTX)
source: myfinsight.com